Advertisement

International Journal of Hematology

, Volume 75, Issue 3, pp 257–260 | Cite as

F-Blast Is a Useful Marker for Differentiating Hypocellular Refractory Anemia From Aplastic Anemia

  • Jong Weon Choi
  • Masahiko Fujino
  • Masafumi Ito
Rapid Communication

Abstract

Making a morphologic distinction between hypocellular refractory anemia (hypo RA) and aplastic anemia (AA) is difficult. To investigate the significance of hemoglobin F-containing erythroblasts (F-blasts) and p53 expression in making the distinction between hypo RA and acquired AA, we immunohistochemically assessed F-blasts and p53 in bone marrow specimens from 16 patients with hypo RA, 31 patients with acquired AA, and 15 hematologically normal individuals. F-blast production was elevated in 87.5% (14/16) of patients with hypo RA, but in only 3.2% (1/31) of patients with AA (P < .01). p53 was over-expressed in 75.0% (12/16) of hypo RA patients and in 6.4% (2/31) of AA patients (P < .01). The mean contents of F-blasts and p53-positive cells in patients with hypo RA were 6.31% ± 3.27% and 7.54% ± 4.36%, respectively, of all bone marrow cells, which were significantly higher than for patients with AA (0.35% ± 0.46% and 0.58% ± 1.29%, P < .01). In conclusion, a high prevalence of elevated F-blast production is noted in hypo RA, suggesting that the assessment of F-blasts in bone marrow can be used as an additional tool for differentiating hypo RA from acquired AA.

Key words

Hypocellular refractory anemia Aplastic anemia F-blasts p53 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Boyer SH, Belding TK, Margolet L, Noyes AN. Fetal hemoglobin restriction to a few erythrocytes (F-cells) in normal human adults.Science. 1975;188:361–363.CrossRefPubMedGoogle Scholar
  2. 2.
    Reinhardt D, Haase D, Schoch C, et al. Hemoglobin F in myelodys-plastic syndrome.Ann Hematol. 1998;76:135–138.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Yoshida Y, Anzai N, Kawabata H. Apoptosis in myelodysplasia: a paradox or paradigm.Leuk Res. 1995;19:887–891.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Elghetany MT, Vyas S, Yuoh G. Significance of p53 overexpression in bone marrow biopsies from patients with bone marrow failure: aplastic anemia, hypocellular refractory anemia, and hypercellular refractory anemia.Ann Hematol. 1998;77:261–264.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Elghetany MT. p53 overexpression in bone marrow biopsies in refractory anemia and aplastic anemia: impact of antibody selection.Leuk Res. 2000;24:975–977.CrossRefPubMedGoogle Scholar
  6. 6.
    Choi JW, Kim Y, Fujino M, Ito M. A new anti-hemoglobin F antibody against synthetic peptide for the detection of F-cell precursors (F-blasts) in bone marrow.Int J Hematol. 2001;74:277–280.CrossRefPubMedGoogle Scholar
  7. 7.
    Elghetany MT, Hudnall SD, Gardner FH. Peripheral blood picture in primary hypocellular refractory anemia and idiopathic acquired aplastic anemia: an additional tool for differential diagnosis.Haematologica. 1997;82:21–24.PubMedGoogle Scholar
  8. 8.
    Fohlmeister I, Fischer R, Modder B, Rister M, Schaefer HE. Aplas-tic anemia and the hypocellular myelodysplastic syndrome.J Clin Pathol. 1985;38:1218–1224.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Kurotaki H, Tsushima Y, Nagai K, Yagihashi S. Apoptosis, bcl-2 expression and p53 accumulation in myelodysplastic syndrome, myelodysplastic syndrome-derived acute myelogenous leukemia and de novo acute myelogenous leukemia.Acta Haematol. 1999;102:115–123.CrossRefGoogle Scholar
  10. 10.
    Kikukawa M, Aoki N, Sakamoto Y, Mori M. Study of p53 in elderly patients with myelodysplastic syndromes by immunohistochem-istry and DNA analysis.Am J Pathol. 1999;155:717–721.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© The Japanese Society of Hematology 2002

Authors and Affiliations

  • Jong Weon Choi
    • 1
    • 2
  • Masahiko Fujino
    • 3
  • Masafumi Ito
    • 1
  1. 1.Department of PathologyNagoya University HospitalNagoyaJapan
  2. 2.Department of Clinical Pathology, College of MedicineInha UniversityInchonKorea
  3. 3.First Department of PathologyNagoya University School of MedicineNagoyaJapan

Personalised recommendations